ANI Pharmaceuticals
ANIP
#5081
Rank
A$1.96 B
Marketcap
$93.30
Share price
5.24%
Change (1 day)
13.60%
Change (1 year)

Earnings for ANI Pharmaceuticals (ANIP)

Earnings in 2024 (TTM): A$54.76 Million

According to ANI Pharmaceuticals's latest financial reports the company's current earnings are A$0.53 Billion. In 2023 the company made an earning of A$30.17 Million, an increase over its 2022 earnings that were of -A$95.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ANI Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$54.76 M81.47%
2023 A$30.17 M-131.71%
2022 -A$95.17 Million11.79%
2021 -A$85.13 Million115.92%
2020 -A$39.43 Million-922.36%
2019 A$4.79 M-84.26%
2018 A$30.44 M22.64%
2017 A$24.82 M88.4%
2016 A$13.17 M-60.07%
2015 A$33 M12.15%
2014 A$29.42 M-899.29%
2013 -A$3.69 Million-91.27%
2012 -A$42.17 Million-46.02%
2011 -A$78.12 Million17.96%
2010 -A$66.23 Million18%
2009 -A$56.12 Million103.96%
2008 -A$27.52 Million128.68%
2007 -A$12.04 Million-330.34%
2006 A$5.22 M-136.98%
2005 -A$14.13 Million-24.17%
2004 -A$18.63 Million102.51%
2003 -A$9.2 Million58.68%
2002 -A$5.8 Million39.58%
2001 -A$4.16 Million-24.1%
2000 -A$5.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.45 B 737.52%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-A$9.16 Million-116.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.25 B 2,229.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$1.85 Billion-3,513.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.31 Billion-658.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.25 Billion-559.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.90 B 3,426.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.33 B 35,758.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$1.84 B 3,325.62%๐Ÿ‡ฌ๐Ÿ‡ง UK